HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer

Figure 6 HuR, HO-1, and COX-2 protein expression analysis in pancreatic cancer cells. The western blot analysis revealed differences in protein level between control cells and cells treated with gemcitabine (GEM) and cells treated with GEM after HuR silencing (A). The quantitative Western blot analysis revealed the relative concentration of COX-2 (B), HuR (C), and HO-1 (D) in each of the experimental groups. HO-1: Heme oxygenase-1; COX-2: Cyclooxygenase-2; HuR: Human antigen R.